Effects of a calcium antagonist, lacidipine, on experimental focal cerebral ischemia in rats

Japanese Journal of Pharmacology

Volumn 75, Issue 4, 1997, Pages 415-423

  Funato, Hideyuki ^a   Kawano, Hiroyuki ^a   Akada, Yasushige ^a   Katsuki, Yukio ^a   Sato, Masami ^a   Uemura, Akio ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Calcium antagonist; Cerebral blood flow; Energy metabolism; Focal cerebral ischemia; Lacidipine

Indexed keywords

GLUCOSE; LACIDIPINE; LACTIC ACID; NICARDIPINE; PYRUVIC ACID; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; ENERGY METABOLISM; HYDROGEN CLEARANCE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0031460114     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.75.415     Document Type: Article

References (29)

1. Ohtsuka M, Ono T, Hiroi J, Esumi K, Kikuchi H and Kumada S: Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonist. J Cardiovasc Pharmacol 5, 1074-1082 (1983)
2. Takenaka T, Usuda S, Nomura T, Maeno H and Sado T: Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ehtyl ester 5-methyl ester hydrochloride (YC-93). Arzneimttelforschung 26, 2172-2178 (1976)
3. Abe K, Kogure K and Watanabe T: Prevention of ischemic and postischemic brain edema by a novel calcium antagonist (PN-200-110). J Cereb Blood Flow Metab 8, 436-439 (1988)
4. Hadani M, Yong W and Flamm ES: Nicardipine reduces calcium accumulation and electrolyte derangements in regional cerebral ischemia in rats. Stroke 19, 1125-1132 (1988)
5. Siesjö BK: Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1, 155-185 (1981)
6. Raichle ME: The pathophysiology of brain ischemia. Ann Neurol 13, 2-10 (1983)
7. Takakura S, Susumu T, Satoh H, Mori J, Shiino A and Handa J: Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats. Jpn J Pharmacol 56, 547-550 (1991)
8. Germano IM, Bartkowski HM, Cassel ME and Pitts LH: The therapeutic value of nimodipine in experimental focal cerebral ischemia. J Neurosurg 67, 81-87 (1987)
9. Sauter A, Rudin M, Wiederhold K-H and Hof RP: Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals. Am J Med 86, Suppl 4A, 134-146 (1989)
10. Micheli D, Collodel A, Semeraro C, Gaviraghi G and Carpi C: Lacidipine: A calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. J Cardiovasc Pharmacol 15, 666-675 (1990)
11. Kawada T, Sun H-T, Nakazawa M and Imai S: In vitro effects of the new calcium antagonist lacidipine. Jpn J Pharmacol 62, 289-296 (1993)
12. Funato H, Katsuki Y, Yano T, Kawano H, Akada Y, Sato M and Uemura A: Effects of lacidipine, a new dihydropyridine derivative, on various cerebral ischemia models. Folia Pharmacol Jpn 108, 243-257 (1996) (Abstr in English)
13. Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM and Graham DI: Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry 50, 402-410 (1987)
14. Tamura A, Graham DI, McCulloch J and Teasdale GM: Foca cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1, 53-60 (1981)
15. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL and Bartkowski H: Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination Stroke 17, 472-476 (1986)
16. Lundy EF, Solik BS, Frank RS, Lacy FR, Combs DJ, Zelenock GB and D'Alecy LG: Morphometric evaluation of brain infarcts in rats and gerbils. J Pharmacol Methods 16, 201-214 (1986)
17. Kawasaki H, Watanabe S and Ueki S: Effects of psychotropic drugs on pressor and behavioral responses to brain stimulation in unrestrained, unanesthetized rats. Pharmacol Biochem Behav 10, 907-915 (1979)
18. Auckland K, Bower BF and Berliner RW: Measurement of local cerebral blood flow with hydrogen gas. Circ Res 14, 164-187 (1964)
19. Miyake K, Taguchi T, Tanonaka K, Horiguchi T, Takagi N and Takeo S: Benefical effects of naftidrofuryl oxalate on brain regional energy after microsphere-induced cerebral embolism. J Pharmacol Exp Ther 260, 1058-1066 (1992)
20. MacMillan V and Siesjö BK: Brain energy metabolism in hypoxemia. Scand J Clin Lab Invest 30, 127-136 (1972)
21. Atkinson DE: The energy charge of the adenylate pool as a regulatory parameter: Interaction with feedback modifiers. Biochem 7, 4030-4034 (1968)
22. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U and Ojemann RG: Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54, 773-782 (1981)
23. Harris RJ and Symon L: Extracellular pH, potassium, and calcium activities in progressive ischemia of rat cortex. J Cereb Blood Flow Metab 4, 178-186 (1984)
24. Lassen NA and Astrup J: Ischemic penumbra. In Cerebral Blood Flow - Physiologic and Clinical Aspects, Edited by Wood JH, pp 458-466, McGraw-Hill Book Company, New York (1987)
25. Folbergrova J, Memezawa H, Smith M-L and Siesjo BK: Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats. J Cereb Blood Flow Metab 12, 25-33 (1992)
26. Mies G, Ishimura S, Xie Y, Seo K and Hossmann K-A: Ischemic threshold of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 11, 753-761 (1991)
27. Sauter A, Rudin M and Wiederhold K-H: Reduction of neuronal damage in irreversible cerebral ischemia by Ca antagonist. Neurochem Pathol 9, 211-236 (1988)
28. Berger L and Hakim A: Calcium channel blockers correct acidosis in ischemic rat brain without altering cerebral blood flow. Stroke 19, 1257-1261 (1988)
29. Yoshinaga M, Sadoshima S, Ibayashi S, Ishituka T and Fujishima M: The effect of oral administration of Ca-antagonist (Nilvadipine) on cerebral blood flow and metabolism in experimental brain ischemia. Jpn J Stroke 13, 333-340 (1991) (Abstr in English)